You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

β-amyloid

Showing 1 - 25 of 1,763
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Association of ß-amyloid 40 and 42 With Prediabetes

Completed
  • PreDiabetes
  • Plasma β-amyloid 40 and 42 concentration
  • (no location specified)
Sep 4, 2021

Alzheimer Trial in Boston (Transcranial Alternating Current Stimulation (tACS))

Completed
Has Results
  • Alzheimer Disease
  • Transcranial Alternating Current Stimulation (tACS)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Aug 18, 2022

Medicare Anti-Aß mAb Coverage With Evidence Development Study

Recruiting
  • Mild Alzheimer's Disease
  • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
  • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
  • Baltimore, Maryland
    Centers for Medicare and Medicaid Services
Sep 21, 2023

Alzheimer Trial in United States (AV-1959D, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • AV-1959D
  • Placebo
  • Phoenix, Arizona
  • +5 more
Dec 22, 2022

Amyloid-ß Clearance Mechanisms in Alzheimer's Disease

Recruiting
  • Alzheimer's Disease (AD)
  • positron emission tomography (PET)
  • München, Bayern, Germany
    Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU
Sep 16, 2021

Alzheimer Trial in Canada, United States (18F-Flortaucipir radiopharmaceutical, 18F-MK-6240 radiopharmaceutical, Amyloid-ß

Recruiting
  • Alzheimer Disease
  • 18F-Flortaucipir radiopharmaceutical
  • +2 more
  • Berkeley, California
  • +7 more
Jan 23, 2023

Alzheimer Trial in Baltimore ([18F]P16-129)

Completed
  • Alzheimer Disease
  • Baltimore, Maryland
    Johns Hopkins Medical Institutions
Jul 16, 2021

Sleep, Alzheimer Trial in Saint Louis (Suvorexant 20 mg, Placebo)

Recruiting
  • Sleep
  • Alzheimer Disease
  • Suvorexant 20 mg
  • Placebo
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 15, 2022

Glioblastoma Trial in Bayamon, San Juan (Amyvid, Intravenous Solution)

Not yet recruiting
  • Glioblastoma
  • Amyvid, Intravenous Solution
  • Bayamon, Puerto Rico
  • +1 more
Apr 18, 2023

High Frequency Imaging in Cerebral Amyloid Angiopathy

Recruiting
  • Cerebral Amyloid Angiopathy
  • MR Imaging
  • Bonn, Germany
  • +2 more
Nov 7, 2023

Cardiomyopathies, Primary Trial ((18F)Flutemetamol)

Recruiting
  • Cardiomyopathies, Primary
  • New Haven, Connecticut
    Yale University
Oct 11, 2022

Alzheimer Trial in New Haven (Amyvid)

Recruiting
  • Alzheimer Disease
  • New Haven, Connecticut
    Invicro
Dec 7, 2021

BEAM: Brain-Eye Amyloid Memory Study

Recruiting
  • Alzheimer's Disease
  • +4 more
  • Pittsburgh Compound B [11C]-PIB
  • Toronto, Ontario, Canada
  • +4 more
Oct 24, 2022

Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

Recruiting
  • Amyloidosis, Primary
  • Cardiomyopathy
  • F-18 florbetapir/C-11 acetate PET
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens' Hospital
Oct 23, 2022

PET Measures of CSF Clearance in Preclinical Alzheimer's Disease

Completed
  • Mild Cognitive Impairment
    • New York, New York
      Weill Cornell Medicine
    Oct 18, 2022

    Hypertension Trial in Dallas (Standard Care, Intensive Treatment)

    Active, not recruiting
    • Hypertension
    • Standard Care
    • Intensive Treatment
    • Dallas, Texas
      UT Southwestern Medical Center
    Aug 11, 2022

    Alzheimer's Disease Trial in Richmond (10 GY in 5 daily fractions, 20 GY in 10 daily fractions)

    Terminated
    Has Results
    • Alzheimer's Disease
    • 10 GY in 5 daily fractions
    • 20 GY in 10 daily fractions
    • Richmond, Virginia
      Virginia Commonwealth University
    Nov 18, 2021

    Identifying Biomarkers in Alzheimer's Disease

    Recruiting
    • Neuro-Degenerative Disease
    • Alzheimer Disease
      • Hong Kong, Hong Hong, Hong Kong
        Chinese University of Hong Kong
      Dec 9, 2022

      Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)

      Recruiting
      • Multiple Sclerosis
      • 18F-florbetaben PET/CT
      • Pavia, PV, Italy
        ICS Maugeri SpA SB IRCCS
      Mar 23, 2023

      Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers

      Recruiting
      • Cognitively Normal Older Adults
      • +3 more
      • Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
      • PCP
      • Dallas, Texas
        University of Texas Southwestern Medical Center
      Dec 1, 2022

      Cerebral Amyloid Angiopathy Trial in Beijing (Remote ischemic conditioning)

      Recruiting
      • Cerebral Amyloid Angiopathy
      • Remote ischemic conditioning
      • Beijing, Beijing, China
        Xuan Wu Hospital，Capital Medical University
      Jan 12, 2022

      Mild Cognitive Impairment, Alzheimer 1 Trial in Morgantown (Aducanumab, Exablate Model 4000 Type 2)

      Recruiting
      • Mild Cognitive Impairment
      • Alzheimer Disease 1
      • Morgantown, West Virginia
        West Virginia University Rockefeller Neuroscience Institute
      Jul 19, 2022

      Alzheimer, Memory Complaint, Memory Disorders Trial in Paris (procedure, radiation, biological)

      Not yet recruiting
      • Alzheimer Disease
      • +2 more
      • Electroencephalogram (EEG)
      • +6 more
      • Paris, Ile De France, France
        Hôpital Pitié Salpêtrière
      Apr 7, 2023

      Lewy Body Disease Trial in Jacksonville, Rochester (18F-Flortaucipir)

      Enrolling by invitation
      • Lewy Body Disease
      • Jacksonville, Florida
      • +1 more
      Dec 1, 2022

      OCTA Factors in or Without Amyloid Pathology: A Prospective

      Completed
      • Alzheimer Disease
      • +4 more
        • Busan, Korea, Republic of
          Pusan National University Hospital
        Jul 24, 2022